HIV/AIDS

Wednesday, 21 May 2008 08:31

Government Acts on Toxic Drug

Written by
The government has now decided to reduce the dosage of an antiretroviral drug that has raised health concerns, especially in developing countries for its high toxicity among some patients using it.

While HIV advocates have for many years been asking for the removal of stavudine 40mg from the first line drugs after studies showed its ability to cause grave side-effects on number of patients, the government never took action.

A source at the Ministry of Health said they had ordered many stocks of the Stavudine 40mg, and the country was going to make major losses if it cancelled the contracts. Also, the patients were going to suffer as new combination had not been identified and modalities to shift them to the new regimen.

As they play innocently in the compounds of displace persons, the smiles of HIV positive children belie the harrowing and near death situation they are in.

International agencies have just issued an alert that a significant number of the 12,000 children on antiretroviral (ARVs) drugs are part of the displaced persons and are unable to access their medication.

Kenyans will now have to wait for a couple of months before the much anticipated AIDS vaccine trials in Kagemi takes off, following disappointing results of a different HIV vaccine trial conducted by Merck and Company.

The Kenya AIDS Vaccine Initiative (KAVI) research team has already written to local regulatory authorities informing them of the delay. In the communication they also explain that while the Merck and their vaccine are designed on the same concept, they are fundamentally different in other aspects. 

Friday, 16 November 2007 17:42

Families living with the mentally ill

Written by
As they spend much of the day walking aimlessly in an enclosure or basking in the sun in the restricted compounds of Mathari Hospital away from their families and relatives, one would be forgiven to think these mentally ill persons are harmless.

But findings of a recent study on the relationship between them and their families or relatives now shows that taking care of such patients leaves family members just as worse-off as the patient.
Kenya’s falling HIV/AIDS rates may not be telling the true story of what is happening on the fight against the disease, raising questions on the appropriateness of the Aids prevalence as an indicator of performance.

HIV/AIDS experts who talked to the Horizon said Aids prevalence indicator should not be used as it provides misleading indications once the prevalence falls below 10 per cent.
Friday, 16 November 2007 17:03

Scientists divided over male circumcision

Written by
While several scientists and leading research institutions continue to vouch for male circumcision as an effective way of preventing HIV infections, there are those who are warning against rushing to adopt it as a strategy.

Those who think circumcision may not be the answer to reducing HIV infections argue that there is no significant difference in HIV prevalence rates between communities that circumcise and those which do not.
The government is in the advanced stages of developing a policy that will see men and young boys circumcised as part of the HIV prevention strategy to help them stave-off the virus.

If you do not believe in God or Worship at least once week, you may need to rethink your behavior in light of findings of a recent survey that shows Kenyans who have no religion to be the hardest hit with HIV.

Final findings of Kenya AIDS Indicator Survey (KAIS) to be released in a couple of weeks from now are reporting that HIV prevalence among people without a religion stand at 7.7 per cent against the national average of 7.1 per cent. Last year, when the preliminary findings of the survey were made public, this statistics were not part of them.  

Numerous microbicidal products, designed to be inserted into the vagina and or rectum prior to sexual 

intercourse for the prevention of HIV and other sexually transmitted infections are still being developed.

Numerous microbicidal products, designed to be inserted into the vagina and or rectum prior to sexual intercourse for the prevention of HIV and other sexually transmitted infections are still being developed.

A few years ago women had been given hope of protecting themselves from HIV infection by use of microbicides.

Even though the idea sounded revolutionary then, it was embraced with tremendous optimism.

Sign up

AWC maintains a constant flow of well-researched feature stories and publications

Read → Feature articles | Commentary Service | Newspapers | Reports | Books


Fill in your email address to get highlights from our publications

Publications

  • 1